Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
None listed
Sponsors
none
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of Essential Hypertension / Stage I Hypertension. 2.Patients between the age group of 30-65 years. 3.Patients suffering from Stage I Hypertension.
Exclusion criteria
Exclusion criteria: 1.Patients of Secondary Hypertension. 2.patients with any other comorbities e.g. Diabetes Mellitus, thyroid disorders, CCF, Multiorgan failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the In-silico binding of Drug ligands on Protein Aminopeptidase A by the process of Molecular Docking.To assess the efficacy of selected compounds on the patients of Essential Hypertension.To assess the efficacy of Gomutra bhavit selected compounds on the patients of Essential Hypertension.To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 6weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effect of selected compounds and Gomutra bhavit selected compounds and modern treatment regimen.Timepoint: 3 month | — |
Countries
India
Contacts
Public ContactProf O P Singh
Dept of Kayachikitsa FoAy IMS Banaras Hindu University
Outcome results
None listed